Effect of immobilization of the recombinant human bone morphogenetic protein 2 (rhBMP-2) on anodized implants coated with heparin for improving alveolar ridge augmentation in beagle dogs: Radiographic observations.
10.4047/jkap.2013.51.4.307
- Author:
So Hyoun LEE
1
;
Jae Young JO
;
Mi Jung YUN
;
Young Chan JEON
;
Jung Bo HUH
;
Chang Mo JEONG
Author Information
1. Department of Prosthodontics, School of Dentistry, Institute of Translational Dental Sciences, Pusan National University, Yangsan, Korea. cmjeong@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Anodized implants;
Dopamine;
Heparin;
Bone morphogenetic protein
- MeSH:
Alveolar Process*;
Alveolar Ridge Augmentation*;
Animals;
Bone Development;
Bone Morphogenetic Protein 2*;
Bone Morphogenetic Proteins*;
Dihydroxyphenylalanine;
Dogs*;
Dopamine;
Heparin*;
Humans*;
Immobilization*;
Titanium
- From:The Journal of Korean Academy of Prosthodontics
2013;51(4):307-314
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study was to evaluate the effect of immobilization of the recombinant human bone morphogenetic protein 2 (rhBMP-2) on anodized titaum implants coated with heparin to enhance the vertical alveolar ridge augmentation in the supraalveolar peri-implant defect region. MATERIALS AND METHODS: 18 pure titanium implants (7.0 mm in length, 3.5 mm in diameter) were manufactured for this study. All implants were anodized and designed insertion reference line marked with laser at the apical 2.5 mm from the fixture platform. Implantation of 6 noncoated anodized implants (Control group), 6 anodized implants physically adsorbed with rhBMP-2 by dip and dry method (BMP group) and 6 anodized implants chemically immobilized 3,4-dihydroxyphenylalanine (DOPA)-heparin/rhBMP-2 (Hep-BMP group) was performed in the both mandibular of three male adult beagle dogs using split-mouth design. Radiologic examinations were performed immediately after implant placement and 4 and 8 weeks after implant placement. The amount of mesio-distal bone augmentation was evaluated by measuring the vertical distance from the platform to the marginal bone. Statistical analysis was performed using one-way analysis of variance (SPSS version 18.0) and multiple comparison analysis of The Kruskal-Wallis test and the Mann-Whitney U test. Statistical significance was established at the 5%significant level. RESULTS: At the 4 weeks vertical alveolar ridge augmentation of Control group, BMP group and Hep-BMP group is 0.09 +/- 0.22 mm, 1.02 +/- 0.72 mm, and 1.29 +/- 0.51 mm, At the 8 weeks 0.11 +/- 1.26 mm, 1.11 +/- 0.58 mm, 1.59 +/- 0.79 mm according to radiographic observations. The two experimental groups showed a significantly increasing in vertical bone height compared with the control group (P<.05). However, there is no significant difference between the BMP group and Hep-BMP group (P>.05). CONCLUSION: The rhBMP-2 coated implants were enhanced the vertical bone growth in the supraalveolar peri-implant defect area. However, there is no significant difference between chemically and physically coating method.
